The device, WilloMD, functions as “a GPS for joint pain,” the company said in a release. It aims to address toxic joint system by giving patients an immune system boost to help repair and heal toxicity and inflammation brought on by injury. With age and increased damage, this repair process slows and toxicity can accumulate, damaging cartilage, soft tissue and meniscus, the release said.
Related Articles on Pain Management:
Study Finds Link Between Opioid Use, Hypogonadism
Lyrica No More Effective Than Placebo Painkillers
Patients With Celiac Disease More Likely to Suffer Migraines
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
